Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.
Medicinal chemistry and nanomedicine for reproductive cancer therapeutics
, Sunil Singhal 21 Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Emory University, Atlanta, GA 30322, USA
2 Division of Thoracic Surgery, University of Pennsylvania School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
*Author to whom correspondence should be addressed.
Abstract
Nanomedicine is an interdisciplinary research field where chemistry, physics, biology, engineering, nanotechnology, and medicine meet one other. Many novel nanoparticles have been designed, synthesized, and evaluated for selective targeting of cancer cells, delivering, and releasing the anticancer drugs in a controlled manner. In this review article we discuss the current status and future prospects of medicinal chemistry of nanomedicine with particular attention to nanoparticle systems that are in various stages of development for cancer therapy in reproductive medicine.
Keywords
- Medicinal chemistry
- Cancer
- Therapeutics
- Nanomedicine
- Nanotechnology
- Nanoparticle
- Breast cancer
- Cervical cancer
- Ovarian cancer
- Prostate cancer
- Renal cell carcinoma
- Testicular cancer
- Anticancer drugs
- Review